GLPBio

CRISPR/Cas9

Read More about this category

CRISPR/Cas9 (Clustered Regularly-Interspaced Short Palindromic Repeats/Cas9) is a bacterial immune system that has been adapted for genome editing in mammalian cells. Cas9 is a programmable nuclease that generates double-stranded breaks (DSB) in DNA dictated by binding of a ~20 nucleotide recombinant “guide RNA” (gRNA) to the target site. DSB’s produced by Cas9 are most often repaired through the cell’s error-prone non-homologous end joining (NHEJ) pathway, resulting in small insertions or deletions (indels). The vast majority of indels shift the reading frame, introducing a premature stop codon or resulting in nonsense mediated decay of the mRNA-effectively “knocking out” a gene.

The CRISPR/Cas9 system has substantially advanced efforts in specific gene editing and has been successfully applied to modify the episomal genomes of human and other organisms. The CRISPR/Cas9 system utilizes a prokaryotic RNA-guided programmable nuclease that can make a double-strand DNA break (DSB) at a specific site under the guidance of a leading RNA. This DSB process depends on the co-expression of two basic components: a guide RNA (gRNA) and Cas9 nuclease. Making a specific DSB can trigger DNA repair via either error-prone non-homologous end joining (NHEJ) or homology-directed repair (HDR). In the presence of the CRISPR/Cas9 system, the NHEJ inhibitor SCR7 is proven to increase the efficiency of Cas9-mediated HDR by at least by 7-fold in mammalian cells. Genome editing via CRISPR/Cas9 has become an efficient and reliable way to make precise, targeted changes to the genome of living cells.

Products Related to CRISPR/Cas9(9)

  • GC10637 structure
    GC10637Zidovudine
    CAS: 30516-87-1
    Purity: >99.50%

    Zidovudine es un análogo de nucleósidos sintéticos que bloquea la replicación del virus de la inmunodeficiencia humana (HIV) al inhibir la transcriptasa inversa

  • GC11251 structure
    GC11251NU7441 (KU-57788)
    CAS: 503468-95-9
    Purity: >99.50%

    NU7441 (KU-57788) es un inhibidor altamente potente y selectivo de la proteína quinasa dependiente de ADN (DNA-PK) con un IC50 de 13nM. NU7441 también inhibe la fosfatidilinositol 3-quinasa (PI3K) y el objetivo mamífero de la rapamicina (mTOR) con IC50 de 5,0 y 1,7μM, respectivamente.

  • GC12106 structure
    GC12106SCR7
    CAS: 1533426-72-0
    Purity: >97.50%

    SCR7 es un inhibidor de molécula pequeña de la ligasa IV del ADN,que inhibe la vía de unión final no homóloga (NHEJ) al unirse al dominio de unión al ADN(DBD) de la ligasa IV.

  • GC14075 structure
    GC14075Nocodazole
    CAS: 31430-18-9
    Purity: >98.00%

    Nocodazole es un fármaco antimitótico y un inhibidor rápido y reversible de la polimerización de los microtúbulos. Inhibe Abl, Abl (E255K) y Abl (T315I) en ensayos libres de células con valores de IC50 de 0.21μM, 0.53μM y 0.64μM, respectivamente.

  • GC15743 structure
    GC15743L-755,507
    CAS: 159182-43-1
    Purity: >98.00%

    L-755,507 es un potente agonista selectivo de β3-AR con una CI50 de 35 nM.

  • GC16265 structure
    GC16265RS-1
    CAS: 312756-74-4
    Purity: >98.50%

    RS-1 es un activador RAD51 y también aumenta las eficiencias de activaciÓn mediadas por CRISPR/Cas9.

  • GC17683 structure
    GC17683Brefeldin A
    CAS: 20350-15-6
    Purity: >99.50%

    Brefeldin A es una lactona macreocíclica fúngica y un inhibidor potente y reversible de la formación de vesículas intracelulares y el tráfico de proteínas entre el retículo endoplásmico(RE) y el aparato de Golgi.

  • GC64111 structure
    GC64111BRD0539
    CAS: 1403838-79-8
    Purity: >98%

    BRD0539 es un inhibidor de CRISPR-Cas9 permeable a las células y no tÓxico.

  • GC68804 structure
    GC68804BRD7586
    CAS: 895460-70-5
    Purity: >99.00%

    BRD7586 es un inhibidor de pequeñas moléculas de permeabilidad celular para SpCas9. BRD7586 es el inhibidor anti-CRISPR más pequeño conocido.